Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 15, 2016

Total Value: $57.03M (100.0% shares, 0.0% debt)

Holdings (18)

— Corbus Pharmaceuticals HLDGS 29.3%

Value $16.72M Shares 2,563,925 Est. Cost $2.53 Unrealized —

— Abeona Therapeutics Inc 14.1%

Value $8.036M Shares 1,359,767 Est. Cost $5.06 Unrealized —

— Synthetic Biologics Inc. 11.6%

Value $6.609M Shares 3,734,149 Est. Cost $1.55 Unrealized —

— Vascular Biogenics LTD 7.7%

Value $4.406M Shares 860,605 Est. Cost $4.61 Unrealized —

— Cempra Inc 7.6%

Value $4.318M Shares 180,800 Est. Cost $31.13 Unrealized —

— Advaxis Inc. 5.0%

Value $2.857M Shares 275,000 Est. Cost $9.03 Unrealized —

— Alcobra Ltd 4.9%

Value $2.799M Shares 1,115,315 Est. Cost $7.08 Unrealized —

VNRX Volition RX LTD 4.5%

Value $2.575M Shares 461,538 Est. Cost $3.75 Unrealized +3.4%

— Ampio Pharmaceuticals Inc. 3.6%

Value $2.081M Shares 2,738,322 Est. Cost $6.03 Unrealized —

— Newlink Genetics Corp 2.6%

Value $1.504M Shares 102,437 Est. Cost $27.98 Unrealized —

ALDX Aldeyra Therapeutics Inc 1.8%

Value $1.038M Shares 135,800 Est. Cost $10.20 Unrealized -40.1%

— Keryx Biopharmaceuticals Inc. 1.8%

Value $1.03M Shares 200,000 Est. Cost $10.21 Unrealized —

— Ritter Pharmaceuticals, Inc 1.5%

Value $869K Shares 526,903 Est. Cost $1.65 Unrealized —

— Advaxis Inc. 1.3%

Value $750K Shares 112,500 Est. Cost $6.02 Unrealized —

— OHR Pharmaceutical Inc 1.0%

Value $568K Shares 205,000 Est. Cost $2.54 Unrealized —

— Bio Blast Pharma Ltd 0.7%

Value $424K Shares 250,970 Est. Cost $7.27 Unrealized —

— Caladrius Biosciences Inc 0.5%

Value $266K Shares 55,781 Est. Cost $1.87 Unrealized —

CSBR Champions Oncology INC 0.3%

Value $184K Shares 111,111 Est. Cost $4.66 Unrealized -59.8%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Corbus Pharmaceuticals HLDGS	2,563,925	$16.72M	29.3%	$2.53	—	COM	21833P103
—	Abeona Therapeutics Inc	1,359,767	$8.036M	14.1%	$5.06	—	COM	00289Y107
—	Synthetic Biologics Inc.	3,734,149	$6.609M	11.6%	$1.55	—	COM	87164U102
—	Vascular Biogenics LTD	860,605	$4.406M	7.7%	$4.61	—	COM	M96883109
—	Cempra Inc	180,800	$4.318M	7.6%	$31.13	—	COM	15130J109
—	Advaxis Inc.	275,000	$2.857M	5.0%	$9.03	—	COM NEW	7624208
—	Alcobra Ltd	1,115,315	$2.799M	4.9%	$7.08	—	SHS	M2239P109
VNRX	Volition RX LTD	461,538	$2.575M	4.5%	$3.75	+3.4%	COM	928661107
—	Ampio Pharmaceuticals Inc.	2,738,322	$2.081M	3.6%	$6.03	—	COM	03209T109
—	Newlink Genetics Corp	102,437	$1.504M	2.6%	$27.98	—	COM	651511107
ALDX	Aldeyra Therapeutics Inc	135,800	$1.038M	1.8%	$10.20	-40.1%	COM	01438T106
—	Keryx Biopharmaceuticals Inc.	200,000	$1.03M	1.8%	$10.21	—	COM	492515101
—	Ritter Pharmaceuticals, Inc	526,903	$869K	1.5%	$1.65	—	COM	767836109
—	Advaxis Inc.	112,500	$750K	1.3%	$6.02	—	W EXP 07/15/201	7624117
—	OHR Pharmaceutical Inc	205,000	$568K	1.0%	$2.54	—	COM NEW	67778H200
—	Bio Blast Pharma Ltd	250,970	$424K	0.7%	$7.27	—	SHS	M20156101
—	Caladrius Biosciences Inc	55,781	$266K	0.5%	$1.87	—	COM	128058104
CSBR	Champions Oncology INC	111,111	$184K	0.3%	$4.66	-59.8%	COMM NEW	15870P307